Seelos Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 30511000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2022-09-30)
Statuscurrent
EntitySeelos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001136261-22-000332 · Open the official SEC filing →
Retrieved: 2026-08-19T09:53:15.866234+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001017491/cash-and-equivalents/2022-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5f6ec5bb-2a3c-4f62-96eb-6ec5e0c4e7a5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies